I sat down recently with our CEO, Vivienne Williams, to ask what are Cellix’s plans for the future and why are we so excited for BIO Interna

In the 3rd part of our 'Building a Biotech' series, our CEO Vivienne Williams, who is at BIO-Europe from November 4-7, discusses business partnering in the life sciences. Coming up to BIO-Europe 2018, an amazing opportunity for businesses to meet and get to know each other, had me considering the role that partnering has to play in the life sciences community, and what it means for Cellix and other SMEs. The collaboration between businesses in life sciences drives innovation

In the second part of our 'Building a Biotech' series, our CEO Vivienne Williams reflects on her time at the European Commission workshop on Technology Transfer in Nanotechnology in Lecce, Italy on the 18th and 19th October, and gives more information on why technology transfer and IP are important for biotechs. This week, I attended the European Commission's workshop on tech transfer in nanotechnology. I decided to outline what I put into and got out of this, and to define w

Our CEO Vivienne Williams talks about LES 2018 and why IP is important for Cellix, for biotech start-ups in general, and for industry, innov